Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial | Zendy

Daša Stupica | Zendy; Maša Velušček | Zendy; Rok Blagus | Zendy; Petra Bogovič | Zendy; Tereza Rojko | Zendy; Tjaša Cerar | Zendy; Franc Strle | Zendy

Open Access

Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial

Author(s) -

Daša Stupica,

Maša Velušček,

Rok Blagus,

Petra Bogovič,

Tereza Rojko,

Tjaša Cerar,

Franc Strle

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx534

Subject(s) - doxycycline , medicine , ceftriaxone , open label , observational study , dermatology , erythema , antibiotics , randomized controlled trial , surgery , microbiology and biotechnology , biology

Several guidelines advocate the same treatment approaches for both early disseminated Lyme borreliosis, manifested as multiple erythema migrans (EM), and early localized Lyme borreliosis, manifested as solitary EM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research